{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:59:07Z","timestamp":1793069947487,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejogrb.2025.01.036","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:29:20Z","timestamp":1737545360000},"page":"13-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapy"],"prefix":"10.1016","volume":"307","author":[{"given":"Chlo\u00e9","family":"Barbier de Reulle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Rebotier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Chopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Treilleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Meeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Ferraioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellie","family":"Heineman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"le Saux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rousset-Jablonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.01.036_b0005","unstructured":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries."},{"key":"10.1016\/j.ejogrb.2025.01.036_b0010","unstructured":"https:\/\/www.pathologyoutlines.com\/topic\/ovarytumorwhoclassif.html."},{"issue":"1","key":"10.1016\/j.ejogrb.2025.01.036_b0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.01.036_b0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12905-024-03100-4","article-title":"Approaches to prevention of gynecological malignancies","volume":"24","author":"Ferrari","year":"2024","journal-title":"BMC Womens Health"},{"issue":"13","key":"10.1016\/j.ejogrb.2025.01.036_b0025","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra1813254","article-title":"Mucinous ovarian carcinoma","volume":"380","author":"Morice","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.01.036_b0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian cancer survival by histotype and disease stage","volume":"111","author":"Peres","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.01.036_b0035","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.3802\/jgo.2024.35.e70","article-title":"MITO group. Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey","volume":"35","author":"Palaia","year":"2024","journal-title":"J Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.01.036_b0040","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S1470-2045(12)70322-4","article-title":"Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies","volume":"13","author":"Collaborative Group on Epidemiological Studies of Ovarian Cancer","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejogrb.2025.01.036_b0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejogrb.2020.11.021","article-title":"A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma","volume":"256","author":"Voutsadakis","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.01.036_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/modpathol.3800510","article-title":"Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases","volume":"19","author":"Vang","year":"2006","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.01.036_b0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/PGP.0b013e3181bbbcc1","article-title":"Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases","volume":"29","author":"Tabrizi","year":"2010","journal-title":"Int J Gynecol Pathol"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.01.036_b0060","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1470-2045(13)70253-5","article-title":"Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study","volume":"14","author":"Sieh","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.01.036_b0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13048-022-01084-z","article-title":"Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis","volume":"16","author":"Yu","year":"2023","journal-title":"J Ovarian Res"},{"issue":"11","key":"10.1016\/j.ejogrb.2025.01.036_b0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10654-019-00540-3","article-title":"Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study","volume":"34","author":"Lundberg","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.01.036_b0075","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/ijc.33012","article-title":"Infertility and ovarian cancer risk: Evidence from nine prospective cohort studies","volume":"147","author":"Jiang","year":"2020","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.01.036_b0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/gyno.1995.1193","article-title":"Fertility therapy in the setting of a history of invasive epithelial ovarian cancer","volume":"58","author":"Bandera","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.01.036_b0085","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0015-0282(03)02214-3","article-title":"Assisted reproduction in patients with early-stage ovarian malignancies","volume":"80","author":"Steinkampf","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.01.036_b0090","article-title":"Jul-Aug;33(7-8):488-97","author":"Fortin","year":"2005","journal-title":"French"},{"issue":"9609","key":"10.1016\/j.ejogrb.2025.01.036_b0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Collaborative Group on Epidemiological Studies of Ovarian Cancer","year":"2008","journal-title":"Lancet"},{"issue":"362","key":"10.1016\/j.ejogrb.2025.01.036_b0100","article-title":"Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study","volume":"26","author":"Iversen","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.01.036_b0105","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ygyno.2022.01.014","article-title":"Hereditary Ovarian Cancer Clinical Study Group. Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation","volume":"164","author":"Xia","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.01.036_b0110","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/01443615.2020.1789960","article-title":"Ever-use of the intra-uterine device and the risk of ovarian cancer","volume":"41","author":"Balayla","year":"2021","journal-title":"J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.01.036_b0115","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1047-2797(01)00213-7","article-title":"Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness","volume":"11","author":"Modugno","year":"2001","journal-title":"Ann Epidemiol"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.01.036_b0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwg177","article-title":"Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study","volume":"158","author":"Tung","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.01.036_b0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2004.07.012","article-title":"Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California","volume":"95","author":"Mills","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.01.036_b0130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/ijgc-00009577-200405000-00003","article-title":"Risk factors for different histological types of ovarian cancer","volume":"14","author":"Parazzini","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.01.036_b0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2007.06.006","article-title":"Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?","volume":"107","author":"Jordan","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.01.036_b0140","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1002\/cam4.5612","article-title":"Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko-EVE)","volume":"12","author":"Sung","year":"2023","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.01.036_b0145","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ijc.26469","article-title":"Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study","volume":"131","author":"Yang","year":"2012","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.01.036_b0150","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/ijc.29471","article-title":"Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort","volume":"137","author":"Fortner","year":"2015","journal-title":"Int J Cancer."},{"issue":"2","key":"10.1016\/j.ejogrb.2025.01.036_b0155","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2004.10.037","article-title":"Histologic types of epithelial ovarian cancer: have they different risk factors?","volume":"96","author":"Kurian","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"24","key":"10.1016\/j.ejogrb.2025.01.036_b0160","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2025.01.036_b0165","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/0284186X.2016.1175660","article-title":"Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol"},{"issue":"9980","key":"10.1016\/j.ejogrb.2025.01.036_b0170","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"Collaborative Group On Epidemiological Studies Of Ovarian Cancer","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.01.036_b0175","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/GME.0000000000000550","article-title":"Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2016","journal-title":"Menopause"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.01.036_b0180","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3389\/fendo.2019.00801","article-title":"Menopausal hormone replacement therapy and the risk of ovarian cancer: a meta-analysis","volume":"3","author":"Liu","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.01.036_b0185","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2015.07.109","article-title":"Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis","volume":"139","author":"Li","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.01.036_b0190","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/ijc.22218","article-title":"Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival","volume":"119","author":"Mascarenhas","year":"2006","journal-title":"Int J Cancer"},{"issue":"35","key":"10.1016\/j.ejogrb.2025.01.036_b0195","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1200\/JCO.2015.60.9719","article-title":"Adjuvant hormone therapy may improve survival in epithelial ovarian cancer: results of the AHT randomized trial","volume":"33","author":"Eeles","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.01.036_b0200","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/cancers15020356","article-title":"Impact of hormone replacement therapy on the overall survival and progression free survival of ovarian cancer patients: a systematic review and meta-analysis","volume":"15","author":"Achima\u0219-Cadariu","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.01.036_b0205","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/AOG.0000000000001396","article-title":"Hormone use after nonserous epithelial ovarian cancer: overall and disease-free survival","volume":"127","author":"Power","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.01.036_b0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejca.2019.04.018","article-title":"Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers","volume":"116","author":"Rousset-Jablonski","year":"2019","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.01.036_b0215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jogoh.2019.03.018","volume":"48","author":"Lavoue","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525000442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525000442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:15:46Z","timestamp":1769843746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525000442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":43,"alternative-id":["S0301211525000442"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.01.036","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}